Six pros and cons:
Pros:
– Monetizing equity. When a private equity firm buys an ASC, it gives provides the opportunity to monetize equity.
– Opportunities to practice. Administrative changes taking place after a private equity firm buys an ASC means physicians’ day-to day activities may be more focused on performance.
– Bulk payments. ASC owners receiving an upfront payment for the sale of the practice can use the funds to help meet financial goals, like retirement.
Cons:
– Lower profits long term. When selling to a private equity firm, physicians and other owners sell a percentage of the profits as well.
– Loss of control. Once an ASC is sold to a private equity firm, the culture and success of the center can change.
– Brief partnerships. Private equity firm investments last for a short period of time, ending in a sale to another firm.
More articles on transactions and valuation:
Vascular Institute opens 2nd Tennessee-based outpatient clinic — 3 insights
Buyer pays $15.4M for Kansas ASC — 3 quick points
Surgery Partners Q1 same-facility revenue up 5%: 5 details
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
